COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Biofields Therapy on Warts (MAGNETIK)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02773719
Recruitment Status : Completed
First Posted : May 16, 2016
Last Update Posted : February 1, 2019
Sponsor:
Information provided by (Responsible Party):
University Hospital, Caen

Brief Summary:

Traditionally, healers are willing to look after, two out of three French citizens have already appealed to them at least once during their lives. Many healers in good faith are exercising their magnetism as a "gift" often inherited from elders. Now, they create interest of doctors who do not hesitate in some cases to ensure their cooperation, to implicitly recognize their mysterious talents. Some serious studies have examined these practices: Several studies have been conducted on the influence of biofield therapies in pain, depression and fatigue in cancer disease. The investigators propose a study of the effect of magnetism on the wart disease whose cure is objectively assessable.

Sixty-two subjects in total would be included, comparing 2 proportions observed: the proportion of healing in the group treated with a "real" biofield therapist (recognized and affiliated to the National Group for Alternative Medicine in France) to the proportion of healing in the group treated with a "fake" biofield therapist (someone assessed as not having capacity to magnetize). The "fake" biofield therapist, placebo, has been trained to replicate gestures during a training validated by an independent recognized biofield therapist.


Condition or disease Intervention/treatment Phase
Wart Energy Medecine Magnetism Other: True Biofield therapy Other: Fake Biofield therapy Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 62 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effect of the Intervention of Biofields Therapy on Warts of the Hands and Feet in Adults: a Prospective, Randomized, Double-blind Trial
Study Start Date : April 2016
Actual Primary Completion Date : November 2018
Actual Study Completion Date : November 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Warts

Arm Intervention/treatment
Experimental: True biofield therapist
Subject will have a 40 minutes therapy with a real biofield therapist to treat the wart
Other: True Biofield therapy
Placebo Comparator: Fake biofield therapist
Subject will have a 40 minutes therapy with a fake biofield therapist to treat the wart
Other: Fake Biofield therapy



Primary Outcome Measures :
  1. disappearance of a common palmar or plantar wart [ Time Frame: week 3 ]

Secondary Outcome Measures :
  1. disappearance of each other wart than the original one 3 weeks after the therapy [ Time Frame: week 3 ]
  2. Percentage of reduction of each wart will be calculated using mean diameter of each wart at W0 and W3 [ Time Frame: week3 ]
  3. Percentage of reduction of each wart will be calculated using mean diameter of each wart at W0 and W3 [ Time Frame: week 3 ]
  4. Disappearance of warts at 6 weeks [ Time Frame: week 6 ]
  5. Level of belief in biofield therapy of the subject [ Time Frame: week 6 ]
    week 0



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Patients with common warts on hands or feet for over at least 3 months are eligible for the study. Patients fulfilling one or more of the following criteria will not be included: lack of informed consent prior to randomization, younger than 18 years or under judicial protection, treated with oral corticotherapy for more than 6 months, immunosuppressed or with history of transplant surgery, undergoing chemotherapy or suspected to have carcinomatous warts, or patients with infected warts, injured warts or already treated within 90 days with chemical processing, medical device, surgery or ever treated with biofield therapy.

Subject will be excluded from the study if its warts was treated by other treatment during protocol.

  • ulcerated wart
  • cancerous wart

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02773719


Locations
Layout table for location information
France
Caen University Hospital
Caen, France
Sponsors and Collaborators
University Hospital, Caen
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: University Hospital, Caen
ClinicalTrials.gov Identifier: NCT02773719    
Other Study ID Numbers: 15-163
First Posted: May 16, 2016    Key Record Dates
Last Update Posted: February 1, 2019
Last Verified: April 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Warts
Papillomavirus Infections
DNA Virus Infections
Virus Diseases
Skin Diseases, Viral
Tumor Virus Infections
Skin Diseases, Infectious
Skin Diseases